Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection

International Immunology

Volumn 9, Issue 11, 1997, Pages 1745-1755

  Silins, Sharon L ^a   Cross, Simone M ^a   Elliott, Suzanne L ^a   Pye, Stephanie J ^a   Burrows, Jacqueline M ^a   Moss, Denis J ^a   Misko, Ihor S ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Epstein Barr virus; Infectious mononucleosis; Repertoire selection; TCR chain; Viral replicative antigen

Indexed keywords

CD8 ANTIGEN; HLA B8 ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER STATE; CD8-POSITIVE T-LYMPHOCYTES; DNA-BINDING PROTEINS; EPITOPES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES, CYTOTOXIC; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 0030734054     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.11.1745     Document Type: Article

References (70)

1. Sixbey, J. W., Shirley, P., Chesney, P. J., Buntin, D. M. and Resnick, L. 1989. Detection of a second widespread strain of Epstein-Barr virus. Lancet ii:761.
2. Henle, G., Lennette, E. T., Alspaugh, M. A. and Henle, W. 1979, Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies. Clin. Exp. Immunol. 36:415.
3. Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A. and Pagano, J. S. 1984. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310:1225.
4. Anagnostopoulos, I., Hummel, M., Kreschel, C. and Stein, H. 1995. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744.
5. Robinson, J. E., Brown, N., Andiman, W., Halliday, K., Francke, U., Robert, M. F., Andersson-Anvret, M., Horstmann, D. and Miller, G. 1980. Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus. N. Engl. J. Med. 302:1293.
6. Khanna, R., Burrows, S. R. and Moss, D. J. 1995. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59:387.
7. Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E. and Moss, D. J. 1992. Localization of Epstein-Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 176:169.
8. Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E. and Rickinson, A. B. 1992. Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 176:157.
9. Silins, S. L., Cross, S. M., Elliott, S. L., Pye, S. J., Burrows, S. R., Burrows, J. M., Moss, D. J., Argaet, V. P. and Misko, I. S. 1996. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J. Exp. Med. 184:1815
10. Steven, N. M., Leese, A. M., Annels, N. E., Lee, S. P. and Rickinson, A. B. 1996. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J. Exp. Med. 184:1801.
11. Kerr, B. M., Kienzle, N., Burrows, J. M., Cross, S., Silins, S. L., Buck, M., Benson, E. M., Coupar, B., Moss, D. J. and Sculley, T. B. 1996. Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. J. Virol. 70:8858.
12. Bogedain, C., Wolf, H., Modrow, S., Stuber, G. and Jilg, W. 1995. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J. Virol. 69:4872.
13. + T cells during infectious mononucleosis which recognize EBV early antigen BHRF1. Virology 219:489.
14. Hedrick, S. M. and Eidelman, F. J. 1993. T lymphocyte antigen receptor. In Paul, W. E., ed., Fundamental Immunology, p. 383. Raven Press, New York.
15. Bowness, P., Moss, P. A. H., Rowland-Jones, S., Bell, J. I. and McMichael, A. J. 1993. Conservation of TCR usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific MHC class I-restricted responses. Eur. J. Immunol. 23:1417.
16. Silins, S. L., Burrows, S. R., Moss, D. J., Khanna, R., Misko, I. S. and Argaet, V. P. 1995. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 182:1.
17. McHeyzer Williams, M. G. and Davis, M. M. 1995. Antigen-specific development of primary and memory T cells in vivo. Science 268:106.
18. Argaet, V. P., Schmidt, C. W., Burrows, S. R., Silins, S. L., Kurilla, M. G., Doolan, D. L., Suhrbier, A., Moss, D. J., Kieff, E., Sculley, T. B. and Misko, I. S. 1994. Dominant selection of an invariant T-cell antigen receptor in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 180:2335.
19. Elliott, S. L., Pye, S. J., Schmidt, C. W., Cross, S. M., Silins, S. L and Misko, I. S. 1997. Dominant cytotoxic T lymphocyte response to the immediate-early transactivator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection. J. Infect. Dis., in press.
20. Henle, G., Henle, W. and Horwitz, C. A. 1974. Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis. J. Infect. Dis. 130:231.
21. Burrows, S. R., Misko, I. S., Sculley, T. B., Schmidt, C. and Moss, D J. 1990. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants. J. Virol. 64:3974.
22. Moss, D. J., Misko, I. S., Burrows, S. R., Burman, K., McCarthy, R. and Sculley, T. B. 1988. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature 331:719.
23. Rickinson, A. B., Finerty, S. and Epstein, M. A. 1977. Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: origin of transformed cells arising in co-cultures with foetal lymphocytes. Int. J. Cancer 19:775.
24. Burrows, S. R., Sculley, T. B., Misko, I. S., Schmidt, C. and Moss, D. J. 1990. An Epstein-Barr virus-specific cytotoxic T-cell epitope in EBV nuclear antigen 3 (EBNA 3). J. Exp. Med. 171:345.
25. Wang, A., Lu, S. D. and Mark, D. F. 1984. Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science 224:1431.
26. Rosenberg, S. A., Grimm, E. A., McGrogan, M., Doyle, M., Kawasaki, E., Koths, K. and Mark, D. F. 1984. Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science 223:1412.
27. Burrows, J. M., Khanna, R., Sculley, T. B., Alpers, M. P., Moss, D. J. and Burrows, S. R. 1996. Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J. Virol. 70:4829.
28. Bishop, C. J., Moss, D, J., Ryan, J, M. and Burrows, S. R 1985. T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T-cell lines. Clin. Exp. Immunol. 60:70.
29. Misko, I. S., Pope, J. H., Hutter, R., Soszynski, T D and Kane, R, G. 1984. HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies. Int. J. Cancer 33:239.
30. Burrows, S. R., Suhrbier, A., Khanna, R. and Moss, D. J. 1992. Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing. Immunology 76:174.
31. Burrows, S. R., Gardner, J., Khanna, R., Steward, I, Moss, D. J., Rodda, S. and Suhrbier, A. 1994. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J. Gen. Virol. 75:2489.
32. Tierney, R. J., Steven, N., Young, L. S. and Rickinson, A. B. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier. J. Virol. 68:7374.
33. Mathes, T., Werner-Favre, C., Tang, H., Zhang, X., Kindler, V. and Zubler, R. H. 1993. Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor α, interleukin (IL)6, IL10, and transforming growth factor β1 mRNAs. J. Exp. Med 178:521.
34. Panzara, M. A., Oksenberg, J. R. and Steinman, L. 1992. The polymerase chain reaction for detection of T-cell antigen receptor expression. Curr. Opin. Immunol. 4:205.
35. Kalams, S. A., Johnson, R. P., Trocha, A. K., Dynan, M. J., Ngo, H. S., D'Aquila, R. T., Kurnick, J. T. and Walker, B. D. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261.
36. Tan, S. S. and Weis, J H. 1992. Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times. PCR Methods Appl. 2:137.
37. Young, L. S., Lau, R., Rowe, M., Niedobitek, G., Packham, G., Shanahan, F., Rowe, D. T., Greenspan, D., Greenspan, J. S., Rickinson, A. B. and Farrell, P. J. 1991. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:2868.
38. Malissen, M., Trucy, J., Letourneur, F., Rebai, N., Dunn, D. E., Fitch, F. W., Hood, L. and Malissen, B. 1988. A T-cell clone expresses two T-cell receptor alpha genes but uses one alpha beta heterodimer for allorecognition and self MHC-restricted antigen recognition. Cell 55:49.
39. Jorgensen, J. L., Esser, U., Fazekas de St Groth, B., Reay, P. A. and Davis, M. M. 1992. Mapping TCR-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224.
40. Garcia, K. C., Degano, M., Stanfield, R. L., Brunmark, A., Jackson, M R., Peterson, P. A., Teyton, L. and Wilson, I. A. 1996 An alpha-beta T cell receptor structure at 2. 5 angstrom and its orientation in the TCR-MHC complex. Science 274:209
41. Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E. and Wiley, D. C. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
42. Roldan. E. Q., Sottini, A., Bettinardi, A., Albertini, A., Imberti, L. and Primi, D. 1995. Different TCRBV genes generate biased patterns of V-D-J diversity in human T-cells. Immunogenetics 41:91.
43. Chang, Y., Chen, M. I., Wu, R., Chang, P., Shu, C. and Liu. S. 1992. Sequence analysis of the BZLF 1 gene of Epstein-Barr virus derived from a new variant isolated in Taiwan. Nucleic Acids Res. 20:139.
44. Packham, G., Brimmell, M., Cook, D., Sinclair, A. J. and Farrell, P. J. 1993. Strain variation in Epstein-Barr virus immediate-early genes. Virology 192:541.
45. Countryman, J. and Miller, G. 1985. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl Acad. Sci. USA 82:4085.
46. Becker, J., Leser, U., Marschall, M., Langford, A., Jilg, W, Gelderblom, H., Reichart, P. and Wolf, H. 1991. Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. Proc. Natl Acad. Sci. USA 88:8332.
47. Bogedain, C., Alliger, P., Schwarzmann, F., Marschall, M., Wolf, H. and Jilg, W. 1994. Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines. J. Virol. 68:1200.
48. Gratama, J. W., Oosterveer, M. A., Zwaan, F. E., Lepoutre, J., Klein, G. and Ernberg, I. 1988. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc. Natl Acad. Sci. USA 85:8693.
49. Yao, Q, Y., Rickinson, A. B. and Epstein, M. A. 1985. A reexamination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int. J. Cancer 35:35.
50. Joab, I., Triki, H., De Saint Martin, J., Perricaudet, M. and Nicolas, J. C. 1991. Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus. J. Infect. Dis. 163:53.
51. Joab, I., Nicolas, J. C. Schwaab, G. de-Thé, G. Clausse, B. Perricaudet, M. and Zeng, Y. 1991. Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int. J. Cancer 48:647.
52. Tedeschi, R., Foong, Y. T., Cheng, H. M., Depaoli, P., Elfborg, T. and Dillner, J. 1995. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes. J. Gen. Virol. 76:1393.
53. Apolloni, A. and Sculley, T. B. 1994. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 202:978.
54. Bachmann, M. F., Oxenius, A., Pircher, H., Hengartner, H., Ashton-Richardt, P. A., Tonegawa, S. and Zinkernagel, R. M. 1995. TAP1-independent loading of class I molecules by exogenous viral proteins. Eur. J. Immunol. 25:1739.
55. Levitsky, V., Zhang, Q., Levitskaya, J. and Masucci, M. G. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183:915.
56. + cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J. Virol. 70:843.
57. Lehner, P. J., Wang, E. C. Y., Moss, P. A. H., Williams, S., Platt, K., Friedman, S. M., Bell, J. I. and Borysiewicz, L. K. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vβ17 gene segment. J. Exp. Med 181:79.
58. Cibotti, R., Cabaniols, J. P., Pannetier, C., Delarbre, C., Vergnon, I., Kanellopoulos, J. M. and Kourilsky, P. 1994. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180:861.
59. Rickinson, A. B. and Kieff, E. 1996. Epstein-Barr Virus. In Fields, B. N., Knipe, D. M. and Howley, P. M., eds, Fields Virology, p 2397. Lippincott-Raven, Philadelphia, PA.
60. Gonnella, R., Angeloni, A., Calogero, A., Farina, A., Santarelli, R., Gentile, G., Arcese, W., Martino, P., Mandelli, F., Frati, L., Faggioni, A. and Ragona, G. 1997. Transcription of latent and replicative Epstein-Barr virus genes in bone-marrow and peripheral-blood mononuclear cells of healthy donors. Int. J. Cancer 70:524.
61. Doherty, P. C. 1995. Anatomical environment as a determinant in viral immunity. J. Immunol. 155:1023.
62. Selin, L. K., Vergilis, K., Welsh, R. M. and Nahill, S. R. 1996. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J. Exp. Med. 183:2489.
63. Yao, Q. Y., Rickinson, A. B., Gaston, J. S. and Epstein, M. A. 1985. In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients. Int. J. Cancer 35:43.
64. Joncas, J., Lapointe, N., Gervais, F. and Leyritz, M. 1977. Unusual prevalence of Epstein-Barr virus early antigen (EBV-EA) antibodies in ataxia telangiectasia. J. Immunol. 119:1857.
65. Ragona, G., Sirianni, M. C., Soddu, S., Vercelli, B., Sebastiani, G., Piccoli, M. and Aiuti, F. 1986. Evidence for disregulation in the control of Epstein-Barr virus latency in patients with aids-related complex. Clin. Exp. Immunol. 66:17.
66. Thomas, J. A., Allday, M. J. and Crawford, D. H. 1991. Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. Adv. Cancer Res. 57:329.
67. Rooney, C. M., Smith, C. A., Ng, C. Y. C., Loftin, S., Li, C., Krance, R. A., Brenner, M. K. and Heslop, H. E. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9.
68. Arden, B., Clark, S. P., Kabelitz, D. and Mak, T. W. 1995. Human T-cell receptor variable gene segment families, Immunogenetics 42:455.
69. Toyonaga, B., Yoshikai, Y., Vadasz, V., Chin, B. and Mak, T. W. 1985. Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. Proc. Natl Acad. Sci. USA 82:8624.
70. Chothia, C., Boswell, D. R. and Lesk, A. M. 1988. The outline structure of the T-cell alpha beta receptor. EMBO J. 7:3745.